UiPath (PATH): Bridgewater Associates reduced its stake -271K shares
Bridgewater Associates reduced its stake in UiPath, per its Q4 2025 13F.
- 2.22M
- Shares reported · -271K vs prior quarter
- 0.13%
- Disclosed portfolio weight
- $36.5M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 13, 2026
What stands out in this filing
- 2,495,625 shares in Q3 2025, 2,224,610 now (−10.9% in share count).
- Reported at $36.5M, 0.13% of the portfolio value in this 13F filing.
- 11 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 22, 2025InsiderOfficer sold ~$77K of PATH shares in the open market
- Dec 12, 2025InsiderCEO sold ~$806K of PATH shares in the open market
- Dec 15, 2025InsiderCEO sold ~$778K of PATH shares in the open market
- Dec 16, 2025InsiderCEO sold ~$732K of PATH shares in the open market
- Dec 17, 2025InsiderCEO sold ~$725K of PATH shares in the open market
- Dec 22, 2025InsiderCEO sold ~$742K of PATH shares in the open market
- Dec 23, 2025InsiderCEO sold ~$742K of PATH shares in the open market
- Dec 24, 2025InsiderCEO sold ~$761K of PATH shares in the open market
- Dec 26, 2025InsiderCEO sold ~$761K of PATH shares in the open market
- Dec 29, 2025InsiderCEO sold ~$740K of PATH shares in the open market
- Dec 30, 2025InsiderCEO sold ~$757K of PATH shares in the open market
- Dec 31, 2025InsiderCEO sold ~$745K of PATH shares in the open market
- Jan 2, 2026InsiderCEO sold ~$737K of PATH shares in the open market
- Jan 5, 2026Insider · 2 peopleInsiders: 2 sales (~$1.8M)
- Jan 6, 2026InsiderCEO sold ~$720K of PATH shares in the open market
- Jan 7, 2026InsiderCEO sold ~$779K of PATH shares in the open market
- Jan 8, 2026InsiderCEO sold ~$787K of PATH shares in the open market
- Jan 9, 2026InsiderCEO sold ~$773K of PATH shares in the open market
- Jan 12, 2026InsiderCEO sold ~$747K of PATH shares in the open market
- Jan 13, 2026InsiderCEO sold ~$773K of PATH shares in the open market
- Jan 14, 2026InsiderCEO sold ~$706K of PATH shares in the open market
- Jan 15, 2026InsiderCEO sold ~$692K of PATH shares in the open market
- Jan 22, 2026InsiderCEO sold ~$676K of PATH shares in the open market
- Jan 23, 2026InsiderCEO sold ~$686K of PATH shares in the open market
- Jan 26, 2026InsiderCEO sold ~$676K of PATH shares in the open market
What came next
- Mar 5, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
- Mar 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On March 24, 2026, the Compensation Committee of the Board of Directors (the “Board”) of UiPath, Inc. (the “Company”) appointed Raghavendra Malpani, the Company’s current Chief Technology Officer, as the Company’s Chief Product and Technology Officer, effective March 25, 2026 (the “Effective Date”).”
- May 28, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for UiPath
For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PATH page.
How this filing works
Explore the data
Common questions
What does this filing report about UiPath (PATH) stock?
Bridgewater Associates reduced its stake in UiPath, per its Q4 2025 13F. Now 2.22M shares, $36.5M reported value, 0.13% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 13, 2026.
What stands out in this filing?
2,495,625 shares in Q3 2025, 2,224,610 now (−10.9% in share count). Reported at $36.5M, 0.13% of the portfolio value in this 13F filing. 11 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about UiPath recently?
For UiPath, OQRO holds 17 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the PATH page.
Does this mean PATH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at UiPath
- SEC Form 4Nov 10, 2026
- SEC Form 144Nov 9, 2026
- SEC Form 4Oct 26, 2026
- SEC Form 144Oct 22, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Oct 19, 2026
Everything OQRO holds on this company is on its PATH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
